Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
To access this article, please choose from the options below
PII: S1386-6532(09)00165-6
doi:10.1016/j.jcv.2009.04.006
© 2009 Elsevier B.V. All rights reserved.
